Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer

Postoperative non-small cell lung cancer (NSCLC) patients require adjuvant therapy to improve their prognosis. In this study, we investigated the efficacy of a sequential combination of autologous cellular immunotherapy (CIT) and chemotherapy for postoperative NSCLC. This retrospective study include...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Main Authors: Pan, Qiu-Zhong, Tang, Yan, Wang, Qi-Jing, Li, Yong-Qiang, Zhang, Li, Li, Xiao-Dong, Zhao, Jing-Jing, Weng, De-Sheng, Liu, Qing, Huang, Li-Xi, He, Jia, Chen, Shi-Ping, Ke, Miao-La, Zeng, Yi-Xin, Xia, Jian-Chuan
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2015
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4570139/
https://ncbi.nlm.nih.gov/pubmed/26405607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1038017
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares